Is a complete EYPT research report available?

No complete published report is available for EyePoint, Inc. (EYPT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

EyePoint, Inc. (EYPT)

NASDAQ: EYPT · USD

$12.9

+0.94 (+7.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EYPT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.1B
Revenue (ttm)	7.6M
Net income (ttm)	-271.6M
EPS (ttm)	-$3.51
Shares out	83.8M
Volume	1,561,104
Beta	1.74
Price target	$40.5	+214.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.6M
Net income (ttm): -271.6M
EPS (ttm): -$3.51
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EYPT indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001314102
Company name	EyePoint, Inc.
Country	United States
Country code	US
Cusip	30233G209
Employees	214
Employees Change	49%
Employees Change Percent	29.7
Enterprise value	$878M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2005-01-27
Isin	US30233G2093
Last refreshed	2026-07-31
Market cap	$1.1B
Market cap category	Small-Cap
Price	$12.86
Price currency	USD
Rev Per Employee	35,579.44x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	3826
Symbol	EYPT
Website	https://eyepoint.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.19%
EV Sales Forward	656.37x
EV/Sales	115.31x
FCF yield	-25.18%
P/B ratio	4.66x
P/S ratio	141.61x
PS Forward	806.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3,700.89%
EBITDA Margin	-3,668.75%
Gross Profit	$-224.7M
Net Income	$-271.6M
Net Income Growth Years	0%
Pretax Margin	-3,564.09%
Profit Per Employee	$-1.3M
ROA	-54.13
Roa5y	-24.33
ROCE	-112.4
ROE	-102.7
Roe5y	-57.01
ROIC	-1,062.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.32%
Cagr15y	-8.28%
Cagr1y	30.58%
Cagr3y	2.79%
Cagr5y	9.23%
EPS Growth Years	0
Revenue Growth	-86.41x
Revenue Growth Q	-97.15x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.38x
Revenue Growth5 Y	-25.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$288.2M
Cash	$222.5M
Current Assets	$249.5M
Current Liabilities	$37.5M
Debt	$22.3M
Debt Equity	$0.1
Equity	$230.5M
Interest Coverage	-8,540.1
Liabilities	$57.7M
Long Term Assets	$38.7M
Long Term Liabilities	$20.3M
Net Cash	$200.2M
Net Cash By Market Cap	$18.57
Net Cash Growth	-31.92%
Net Debt Equity	$-0.87
Tangible Book Value	$230.5M
Tangible Book Value Per Share	$2.76
WACC	13.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.66
Inventory Turnover	137.5
Net Working Capital	$-8.4M
Quick ratio	5.97
Working Capital	$212M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-66.34%
1Y total return	30.56%
200-day SMA	14.1
3Y total return	8.62%
50-day SMA	13.13
50-day SMA vs 200-day SMA	50under200
5Y total return	55.5%
All Time High	72.2
All Time High Change	-82.19%
All Time High Date	2010-12-22
All Time Low	2.19
All Time Low Change	487.21%
All Time Low Date	2022-12-16
ATR	0.9
Beta	1.74
Beta1y	1.91
Beta2y	2.01
Ch YTD	-29.61
High	13
High52	19.11
High52 Date	2025-12-08
High52ch	-32.71%
Low	11.79
Low52	9.4
Low52 Date	2025-08-05
Low52ch	36.81%
Ma50ch	-2.03%
Premarket Change Percent	2.18
Premarket Price	$12.18
Premarket Volume	15,141
Price vs 200-day SMA	-8.79%
RSI	48.1
RSI Monthly	51
RSI Weekly	47.75
Sharpe ratio	0.67x
Sortino ratio	1.13
Total Return	-27.76%
Tr YTD	-29.61
Tr15y	-72.64%
Tr1m	-8.86%
Tr1w	3.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	8
Analyst Price Target Top	$42.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.93
Earnings Revenue Estimate	353,064x
Earnings Revenue Estimate Growth	-93.38x
Operating Income	$-281.8M
Operating margin	-3,701.4
Price target	$40.5
Price Target Change	$215
Price Target Change Top	$230

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,226,922%
Float Percent	74.22%
Net Borrowing	-99,000
Shares Insiders	0.96%
Shares Institutions	82.75%
Shares Out	83,841,298
Shares Qo Q	3.57%
Shares Yo Y	27.76%
Short Float	26.4%
Short Ratio	10.4
Short Shares	19.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-303.2M
Adjusted OCF	-299,230,000
Average Volume	1,499,460.25x
Bv Per Share	2.76
CAPEX	$-4M
Ch10y	-66.34
Ch15y	-72.64
Ch1m	-8.86
Ch1w	3.13
Ch1y	30.56
Ch3y	8.62
Ch5y	55.5
Ch6m	-12.81
Change	7.89%
Change From Open	5.67
Close	11.92
Days Gap	2.1
Depreciation Amortization	2,448,000
Dollar Volume	20,075,797.4
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-281.8M
EBITDA	$-279.4M
EPS	$-3.51
F Score	1
FCF	$-271.5M
FCF EV Yield	-30.93x
FCF Per Share	$-3.24
Financing CF	171,984,000
Fiscal Year End	December
Founded	1,987
Income Tax	$229,000
Investing CF	88,109,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2020-12-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	14.2
Ma150ch	-9.46%
Ma20	13.32
Ma20ch	-3.45%
Net CF	-7,446,000
Next Earnings Date	2026-08-10
Open	12.17
Optionable	Yes
Position In Range	88.43
Post Close	12.86
Postmarket Change Percent	0.68
Postmarket Price	$12.95
Ppne	29,259,000
Pre Close	11.92
Price Date	2026-07-30
Ptbv Ratio	4.68
Relative Volume	1.04x
Revenue	7,614,000x
SBC By Revenue	416.22x
Share Based Comp	31,691,000
Tax By Revenue	3.01x
Tr6m	-12.81%
Us State	Massachusetts
Volume	1,561,104
Z Score	1.37

EyePoint, Inc. (EYPT)

Coverage state: Market snapshot only — no published research

Generate the first EYPT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · EYPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EYPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EYPT

Frequently asked questions